Purchase Order HT001417P0179
Award Date 2/23/17
Potential Completion Date 4/2/21
Potential Value $36K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is to STEMCELL TECHNOLOGIES INC, a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $9,963.30 firm fixed price contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services. The contract is a Blanket Purchase Agreement (BPA) call, which is part of a larger $10,000,000 BPA vehicle that enables STEMCELL TECHNOLOGIES INC...
- This federal contract award, valued at $54,102.50, was issued by the National Institute of Environmental Health Sciences (NIEHS) to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence in Kent, Washington. The contract is for the acquisition of a RoboSep-S automated cell separator, which uses EasySep immunomagnetic cell separation technology to enable positive and negative selection of desired cells from various sample sources. This...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $7,131.73 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for T-cell isolation products needed for research in Dr. Kemper's lab. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This is a federal purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $23,828.70, is for the delivery of REAGENT MATERIALS - EASYSEP HUMAN IMMUNE CELL ISOLATION KITS by the prime contractor, Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is a firm fixed-price purchase order with an ultimate...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence. The $4,828.50 firm fixed-price contract was issued as a Blanket Purchase Agreement (BPA) call, without any set-aside designation. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of EasySep Enrichment Kits, which are specialized cell separation products used in biomedical research, particularly for studies in areas like stem cell research, immunology, cancer, and infectious diseases. The...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $100,836.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit company, to provide EASYSEP ENRICHMENT KITS. This contract has a performance period from July 5, 2017 to July 5, 2018 and was not set aside for a particular type of small business. Stemcell Technologies Inc. is an established federal contractor...
- This federal contract award was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. entity in Kent, Washington. The $6,528 firm-fixed-price contract was awarded on March 16, 2015 as a Blanket Purchase Agreement (BPA) call, with a completion date of May 31, 2015. Stemcell Technologies Inc. was not awarded...